echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > 74 new drugs were added to the National Medical Insurance List and 11 were transferred out

    74 new drugs were added to the National Medical Insurance List and 11 were transferred out

    • Last Update: 2022-01-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In accordance with the decision and deployment of the Party Central Committee and the State Council, the National Medical Security Administration, in conjunction with the Ministry of Human Resources and Social Security and other departments, organized the adjustment of the National Medical Insurance Drug List in 2021, which has now been successfully concluded
    .
    Today, the National Medical Security Administration held a press conference to announce the results of the adjustment of the National Medical Insurance Drug List in 2021
    .
    A total of 74 drugs were added to the catalog and 11 drugs were removed from the catalog
    .
    The total number of drugs in the National Medical Insurance Drug List in 2021 will be 2,860, which will be implemented on January 1, 2022
    .
     
    The scope of the adjustment of theNational Medical Insurance Drug List in 2021 includes drugs newly marketed or modified in their inserts in the past 5 years, national essential drugs, and drugs used for the treatment of new coronary pneumonia
    .
    The newly-incorporated drugs accurately complement the medication needs of tumors , chronic diseases, anti-infections, rare diseases, women and children , and involve a total of 21 clinical groups.
    Patients benefit from a wide range of patients.
    The availability and fairness of medications for the masses has been further improved
    .
     
      After the adjustment, the total number of drugs in the National Medical Insurance Drug List is 2,860, of which 1,486 are Western medicines and 1,374 are Chinese patent medicines
    .
    There are still 892 kinds of Chinese herbal medicines
    .
    During the adjustment, the National Medical Security Administration has always adhered to the functional positioning of "guarantee basic", regarded fund affordability as the "bottom line" that must be adhered to, and strived to meet the basic drug needs of the majority of insured persons
    .
      In accordance with the decision and deployment of the Party Central Committee and the State Council, the National Medical Security Administration, in conjunction with the Ministry of Human Resources and Social Security and other departments, organized the adjustment of the National Medical Insurance Drug List in 2021, which has now been successfully concluded
    .
    Today, the National Medical Security Administration held a press conference to announce the results of the adjustment of the National Medical Insurance Drug List in 2021
    .
    A total of 74 drugs were added to the catalog and 11 drugs were removed from the catalog
    .
    The total number of drugs in the National Medical Insurance Drug List in 2021 will be 2,860, which will be implemented on January 1, 2022
    .
     
    The scope of the adjustment of the   National Medical Insurance Drug List in 2021 includes drugs newly marketed or modified in their inserts in the past 5 years, national essential drugs, and drugs used for the treatment of new coronary pneumonia
    .
    The newly-incorporated drugs accurately complement the medication needs of tumors , chronic diseases, anti-infections, rare diseases, women and children , and involve a total of 21 clinical groups.
    Patients benefit from a wide range of patients.
    The availability and fairness of medications for the masses has been further improved
    .
     
      After the adjustment, the total number of drugs in the National Medical Insurance Drug List is 2,860, of which 1,486 are Western medicines and 1,374 are Chinese patent medicines
    .
    There are still 892 kinds of Chinese herbal medicines
    .
    During the adjustment, the National Medical Security Administration has always adhered to the functional positioning of "guarantee basic", regarded fund affordability as the "bottom line" that must be adhered to, and strived to meet the basic drug needs of the majority of insured persons
    .
      In accordance with the decision and deployment of the Party Central Committee and the State Council, the National Medical Security Administration, in conjunction with the Ministry of Human Resources and Social Security and other departments, organized the adjustment of the National Medical Insurance Drug List in 2021, which has now been successfully concluded
    .
    Today, the National Medical Security Administration held a press conference to announce the results of the adjustment of the National Medical Insurance Drug List in 2021
    .
    A total of 74 drugs were added to the catalog and 11 drugs were removed from the catalog
    .
    The total number of drugs in the National Medical Insurance Drug List in 2021 will be 2,860, which will be implemented on January 1, 2022
    .
     
    The scope of the adjustment of the   National Medical Insurance Drug List in 2021 includes drugs newly marketed or modified in their inserts in the past 5 years, national essential drugs, and drugs used for the treatment of new coronary pneumonia
    .
    The newly-incorporated drugs accurately complement the medication needs of tumors , chronic diseases, anti-infections, rare diseases, women and children , and involve a total of 21 clinical groups.
    Patients benefit from a wide range of patients.
    The availability and fairness of medications for the masses has been further improved
    .
    Drugs Drugs Drugs Tumor Tumor Tumor Children Children Children
     
      After the adjustment, the total number of drugs in the National Medical Insurance Drug List is 2,860, of which 1,486 are Western medicines and 1,374 are Chinese patent medicines
    .
    There are still 892 kinds of Chinese herbal medicines
    .
    During the adjustment, the National Medical Security Administration has always adhered to the functional positioning of "guarantee basic", regarded fund affordability as the "bottom line" that must be adhered to, and strived to meet the basic drug needs of the majority of insured persons
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.